Date/Time: Monday, October 22, 2018 - 3:30 PM to 5:30 PM
Type: Special Interest Group
Room: Hanover C
Chair: Timothy Gershon, MD, PhD – University of North Carolina at Chapel Hill Co-Chair: Santosh Kesari, MD, PhD – John Wayne Cancer Institute Recent discoveries in genomics and stem cell biology have had dramatic effects on brain tumor biology and treatment. Notably, molecular features of brain tumors are now considered during classification. This SIG will review findings demonstrating molecular heterogeneity within brain tumors, the biological mechanisms of tumor development and progression, and new therapies for brain cancer.
To gain new insight into the heterogeneity within brain tumors
To understand the relationship between tumor heterogeneity and treatment response
To learn about new treatment options for patients with brain tumors